NCT04027790View on ClinicalTrials.gov

Plasma-based Colorectal Cancer Screening Research & Development

CompletedOBSERVATIONAL
Enrollment

354

Participants

Timeline

Start Date

May 3, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Colo-rectal Cancer
Interventions
DIAGNOSTIC_TEST

Epi proColon

Analysis of DNA methylation status for Septin9 and additional biomarkers

Trial Locations (5)

19104

University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia

33606

University of South Florida, Tampa

62702

Springfield Clinic, Springfield

63110

Washington University, St Louis

70170

Ochsner Clinic Foundation, New Orleans

Sponsors

Lead Sponsor

Epigenomics, Inc
All Listed Sponsors
lead

Epigenomics, Inc

INDUSTRY

NCT04027790 - Plasma-based Colorectal Cancer Screening Research & Development | Biotech Hunter | Biotech Hunter